Emily Hayes - Aug 05, 2022
We perform significantly better than the EPO average at oppositions
We really are experts when it comes to opposing patents and our enviable success rate speaks for itself. Only 7.4% of all patents that we have opposed over the last 15 years have been maintained as granted. That's significantly better than the EPO’s 15-year average of 24.6%. Our figures are even...
Alternative proteins: you can’t magic anything out of thin air – or can you?
It’s hard to miss the scale of investor and consumer appetite for..
Bugs helping drugs beat cancer – harnessing the microbiome for immunotherapy
In recent years the field of cancer immunotherapy has exploded in..
Most opposed patents of 2021
When we reviewed our list of the most opposed European patents of..
Mewburn Ellis is proud to work on 19 of the 50 top-selling pharmaceuticals of 2021
2021 was a year of unprecedented success for the biotech and..
Breakthrough: super fast DNA tests
A rapid bedside genetic test can screen newborn babies for a genetic..
EPO presses pause on proceedings that depend on the plausibility referral to the EBA
Despite not having any express legislative basis in the European..
The surprising world of canine oncology
Dog cancer specialist Dr Clare Knottenbelt reveals the insights..
Plant-based brands: what does it take to break through?
We investigate what it takes to stand out in an increasingly crowded..
Recipe for success - intellectual property opportunities in future food
The future of food is big business and it’s only going to get bigger..
Vertical farming - finding space to sprout up
One thing the past couple of years have taught a lot of people is..
Replacing the bad with the good – an IP perspective on microbial consortia
Our body hosts trillions of microorganisms that are essential to many..
The search for more sustainable food sources
So much more than nutrition, food can evoke pleasure and excitement..
Plausibility strikes again – BMS blockbuster apixaban patent found invalid by UK High Court
In a recent judgment the UK High Court of Justice revoked European..
Horizons in vaccine production
The scramble for a coronavirus vaccine over the last two years has..
Germany’s world-leading MedTech industry
Germany is synonymous with precision engineering and quality..
A much-needed boost: the future of coronavirus vaccines
Just over two years after our first blog on Covid-19, it appears that..
Powering pacemakers – (don’t) be still, my beating heart
Millions of people around the world depend on implanted medical..
Podcast with Guy Heathers: Singapore's innovation community — trends and technology
Having previously spoken to Guy Heathers, Singapore biotech..
Five patenting pitfalls in future food (and how to avoid them)
In our series on future food, we have explored the exciting..
Exosomes in liquid biopsy: a nanometric particle packed with potential
We are all too familiar with the statistic that 1 in 2 of us will get..
We need to talk about women's health - spotlight on endometriosis
The theme of International Women’s Day 2022 was “Break the Bias”,..
Six ways that 3D printing is revolutionising the biomedical industry
3D-Printing is an additive manufacturing process whereby objects are..
Predicting the unpredictable during pregnancy
For many expectant parents, pregnancy is a time of excitement, yet..
A guide to EPO opposition proceedings by videoconference
EPO oppositions by videoconference only became possible relatively..
Kokumi - a new taste for future foods?
Many of us – at least in the West – grew up with the knowledge that..
As the UPC preparatory period begins, the EPO decides to accept UP requests before the full UPC agreement comes into force
On 18 January 2022, Austria became the thirteenth EU country to..
Austrian parliament unanimously passes legislation to allow the practical preparations for the UPC to begin
On 2 December 2021, Austria became the thirteenth EU country to pass..
The smart healthcare revolution – what does it mean for patent attorneys?
In 2020 the EPO published a report on the global trends in patent..
From academia to patents – a career path to becoming a patent attorney
Camille Terfve spoke to EMBL Careers about what it takes to become a..
Digital therapeutics: the rise of digital health technologies during the Covid-19 pandemic
There is no denying that the Covid-19 pandemic has reshaped many..
New Green IP Report launched
Chambers & Partners 2022 Legal Guide - Band 1 Recommended Firm
We are delighted to have once again been ranked Band 1 in Chambers &..
A snapshot: Patent Landscape in Bioinformatics and Digital Health
In this Forward: On Demand vlog, Christopher Casley gives us an..
Capturing the DNA hydroxymethylome for early-stage cancer detection
Biomarkers are measurable indicators of health or disease and the..
CRISPR - the future of gene editing
In this Forward: On Demand vlog, Joseph Morgan and Alex Galbraith..
Change and Opportunity: SPCs in the post-Brexit era
Supplementary Protection Certificates (SPCs) are incredibly important..
MIP IP Stars - The Rising Stars in IP 2021
Congratulations to Rebecca Anderson-Smith, Callum McGuinn and Ben..
‘IP Access’ fund, an extension of the existing UK IPO IP Audits Plus program
In 2021, innovation really has been a hot topic, with the..
Mewburn Ellis: top tier firm Legal 500 2022
Sensors and sensibility: Caroline Hargrove CBE eyes up the future of healthtech
Years after meeting her as another primary-school parent, Forward..
Three ways future food technologies can improve the sustainability of animal feed
Like many others, lockdown has changed not only the daily rhythm in..
IP priorities for future food companies
The future of food is a hot topic. Whether it is cellular..
The other end of the antibody: Fc modifications as a focus for patent protection
For us antibody nerds, a fascinating aspect of the development of..
Liquid biopsies and the future of cancer treatment
In this Forward: On Demand vlog, Samuel Hart discusses liquid biopsy..
Most opposed patents of 2020
Every year at the EPO about 3000-4000 patents are opposed. This..
A new referral to the EPO’s Enlarged Board of Appeal is plausible
Despite not having any express legislative basis in the European..
Patent Landscape in Bioinformatics and Digital Health Special Report
Our new Special Report, Patent Landscape in Bioinformatics and..
Senolytics are knock, knock, knocking on ageing’s door
In 1974, Bob Dylan asked that we stay forever young. Today, exciting..
Is metformin the key to anti-aging?
By 2050, it is estimated that one quarter of the global population..
First human in vivo CRISPR/Cas9 gene editing results make history
The ability to directly edit a patient’s genome safely and..
IP for forward looking cell therapy businesses
The recently released Mewburn Ellis IP Guide for SMEs sets out IP..
IAM Patent 1000: The World’s Leading Patent Professionals 2021
We are delighted to once again be ranked ‘gold tier’ in IAM PATENT..
Circulating tumour cells: at the forefront of cancer diagnosis and treatment
In cancer patients, “metastasis” occurs as tumour cells break-away..
Cancer diagnosis – new data to support methylation-based liquid biopsy
New study demonstrates enormous potential
Earlier this month, we..
Podcast with Jim Mellon: Cellular agriculture and the new agrarian revolution
Jim Mellon, investor in innovation, entrepreneur and author, joins us..
The technologies helping shape the future of food
In this Forward: On Demand vlog, Fay Allen and Sarah Harvey discuss..
Pharma and Life Sciences Patent Extensions in Europe
Our Special Report Pharma and Life Sciences Patent Extensions in..
Podcast with Sarah Kostiuk-Smith: Validation strategies for pharmaceutical patents in Europe
Sarah Kostiuk-Smith, Partner and Patent Attorney at Mewburn Ellis,..
Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2021
We are delighted to be ranked Tier 1 for Patent Prosecution UK in MIP..
Financial Times Special Report - Europe's Leading Patent Law Firms 2021
We are delighted to once again be recognised in the Financial Times..
Cell therapy: repairing and rebuilding the body
It might be trite to observe, but as the human body is formed of..
Methylomics – analysing DNA methylation signatures to diagnose cancer
Traditional tissue biopsies are a vital aspect of current medical..
Need to Know: why your virome holds enormous value
Our bodies play host to a complex network of viruses, many of which..
Healthy eating means more than just a balanced diet: future foods and fighting the risk of infection
Human health is inextricably linked to food – not least because..
Intellectual property and artificial intelligence in the UK: what might the future hold?
AI is a hot topic for the current UK government. Last year, the UK..
IP for forward-looking life sciences businesses
The recently released Mewburn Ellis IP Guide for SMEs sets out IP..
Diagnosing concussion: liquid biopsy is changing the game
Rugby, along with many other contact sports such as football, boxing..
What's the beef? Using meat terms to describe meat alternatives
With the ‘future foods’ market set to grow exponentially over the..
What is the cancer microbiome?
The “microbiome” is commonly associated with the gut microbiome, but..
Fish-free-fish: making a splash with cellular aquaculture
Whilst the oceans remain as vast and seemingly inexhaustible as ever,..
Jim Mellon: the reluctant gradualist taking on ageing
Forward editor Caitlin Mackesy Davies learns how we might all be able..
Need to know: are we set for a bioprinting boom?
From refashioning foods to fabricating organs, bioprinting is the..
The future of organ transplantation: growing organs from scratch?
Organ transplantation has saved, transformed, and extended countless..
EPO 2020 Patent Index - key trends
The European Patent Office (EPO) recently published its 2020 Patent..
Detecting progress: liquid biopsy in lung cancer
Lung cancer remained the leading cause of cancer death in 2020 with..
Webinar - Antibody patenting practice at the EPO
A new edition of the EPO Examination Guidelines came into force on 1..
Controlled environment agriculture - 5 things to watch
Simon Kremer attended the Agri-TechE “Controlled Environment..
Patenting highly engineered antibodies in Europe
In recent years, antibody engineering has moved into a new phase of..
New EPO Guidelines for Examination of Antibody Inventions
A new edition of the EPO examination guidelines will come into force..
Out of Oz: the remarkable life and times of AMP945
Bringing a new cancer treatment to the public can be a complex..
SARS-CoV-2 variants – reasons to be optimistic
In recent weeks and months, several highly-transmissible variants of..
Conscious consumers deserve better than burgers
As part of our Thought Leaders series, Director and Co-founder of..
How to patent your digital health apps – 5 key considerations
As the technical capabilities of smartphones continue to rise at an..
Bugs and slimes – or protein for modern times?
Current agricultural practices are considered by many to be..
Save our staples: Securing the future of food
Rising global temperatures and rising populations threaten farmers’..
Will the COVID-19 vaccines induce more robust immunity than infection with SARS-Cov-2 itself?
Respiratory viruses such as coronaviruses are notorious for evading..
Deep learning cracks the protein folding problem?
Deep learning has just made a new headline grabbing achievement:..
Go with the flow: the allure of the liquid biopsy
Forward finds out how fresh technologies are providing a way to cut..
First regulatory approval for cultured meat – a major milestone
In December 2020, US company Eat Just were granted regulatory..
Further constitutional challenges to Unified Patent Court Agreement
On 26 November 2020, the German Bundestag approved the ratification..
AstraZeneca/Oxford University vaccine shows efficacy against SARS-CoV-2
AstraZeneca/Oxford University have announced that their SARS-CoV-2..
And then there were two – Moderna SARS-CoV-2 vaccine shows efficacy
Moderna have announced that their SARS-CoV-2 vaccine candidate..
Videoconference Oral Proceedings for EPO Oppositions – an Update
The EPO has announced changes to the Pilot Project for Video..
EPO Zooming to catch-up
UPDATE 6 APRIL 2022: On 6 April 2022, the EPO issued a notice..
Pfizer and BioNTech vaccine provides protection against SARS-CoV-2
Pfizer/BioNTech have now released more data from the Phase 3 clinical..
MycoTechnology wins $1M in protein challenge, accelerating growth of mushroom fermentation platform
Our client, MycoTechnology, has won the Radicle Growth Protein..
Highly-engineered antibodies: evolving the patent strategy
In recent years, antibody engineering has moved into a new phase of..
Personalising medicine based on gut reaction
No, we are not talking about jumping to conclusions, but the..
Hummingbird Bioscience to start clinical trials for SARS-CoV-2-targeted antibody, HMBD-115
Our client, Hummingbird Bioscience, has received..
Chambers & Partners 2020 Legal Guide - Band 1 Recommended Firm
We are pleased to report that Mewburn Ellis has been ranked Band 1 in
MIP IP STARS: The Rising Stars in IP 2020
Congratulations to Rebecca Anderson-Smith, Callum McGuinn and Ben..
Liquid biopsies support precision medicine
The treatment of cancer patients with therapies that are specifically..
Nobel Prize in Chemistry awarded for CRISPR "genetic scissors"
In 2012, Jennifer Doudna and Emmanuelle Charpentier published their ..
Minimally invasive, maximum potential: liquid biopsy is redefining diagnosis
Many of us will know someone who has undergone a biopsy during a..
Mewburn Ellis: top tier firm Legal 500 2021
We are delighted to be ranked top tier for our patent practice in the..
More like the real meal - alternative plant-based proteins
Plant-based protein alternatives have arrived in the UK in a big way,..
Genomics medicine has already proved its potential: the (success) story of non-invasive prenatal testing
We have previously discussed the tremendous progress made towards the..
Making the detection of cancer in liquid biopsies more sensitive
Besides being found within the nucleus and mitochondria of cells, DNA..
Trust at the dinner table: public perception and regulation of novel food technologies
The history of humanity is the history of food technology. From the..
Pepper decision means conventionally bred plants and animals get a chilli reception at the EPO
Dr Ben Tolley and Dr Nick Sutcliffe of the Life Sciences team look at..
Neoantigens: IP considerations for an emerging class of cancer immunotherapy
Recent cell and gene therapy product approvals have allowed the..
The emergence of liquid biopsies as companion diagnostics
The development of liquid biopsies
The term liquid biopsy refers to..
Outstanding in the field - Biotechnology and the search for improved crops
At a time that the media is saturated with COVID-19 news, it can be..
Growing Underground: In the pink
Forward editor Caitlin Mackesy Davies finds out why one of our best..
Beyond cultured meat: Cellular Agriculture and animal products
In recent months, lab-grown meat is getting a lot of attention. As..
Is the future of meat animal-free?
Compelling advancements in cellular science could soon see us..
Most Opposed Patents of 2019
The four thousand or so European patents that are opposed every year..
Oppositions & Appeals: we helped clear a new path to patenting dosage regimes
Case 10 – T 1020/03 (EPO Board of Appeal, 29 October 2004)
A shore thing: eco-friendly seaweed materials
It may be a bother for sunbathers, but seaweed is a promising..
Cellular Agriculture – forecasting innovation
In their recent article in Nature Food, high-profile figures in the..
Oppositions & Appeals: novelty of a patient sub-population
Case 9 – T 734/12 (EPO Board of Appeal, 17 May 2013) ..
UK formally withdraws from the UPC
In a statement to Parliament on 20 July 2020, the government formally..
Are functional foods worth the fuss?
Forward: features discuss and celebrate the best of innovation and..
Five tips for patenting inventions in personalised and stratified medicine
As medical treatments become increasingly bespoke, we reveal some..
Can software be therapeutic?
The simple answer is: yes. Thanks for reading this post, stay tuned..
String theory: how bundling IP rights strengthens bioinformatics products
As part of our Thought Leaders series, Mewburn Ellis Partner Sean..
“Test, test, test” – the importance of diagnostics in pandemic preparedness
While the world waits for a vaccine to be developed and approved for..
Protecting IP in bioinformatics and digital health: tips and tricks to tackle the “moving target problem”
As previously discussed, data driven approaches have revolutionised..
Supreme Court confirms strict line on insufficiency in the UK
On 24 June 2020, the UK Supreme Court (UKSC) confirmed the UK courts’..
Oppositions & Appeals: we helped determine the meaning of “surgery”
Case 8 – T 1695/07 (EPO Board of Appeal, 28 September 2011) ..
Cellular immunity – a contributor to COVID-19 “dark matter”?
Immunologist Karl Friston of University College London has theorized..
A Guide to Patenting Bioinformatics Inventions at the EPO: what is technical and why does it matter?
Many inventions in the field of bioinformatics (a term that we will..
Financial Times: Europe's Leading Patent Law Firms 2020
We are delighted to once again be recognised in the Financial Times’..
IAM Patent 1000: The World’s Leading Patent Professionals 2020
We are delighted to once again be ranked ‘highly recommended’ in ‘IAM..
Can CRISPR help us in the fight against COVID-19?
As countries across the world continue to face widespread disruption..
Links between COVID-19 severity and the immune system
The mechanism through which SARS-CoV-2, the virus that causes..
Have we entered the era of the DIY superhuman?
Self-improvement products are everywhere around us, on our..
G3/19 The Enlarged Board of Appeal has its cake and eats it
On 14 May 2020, the Enlarged Board of Appeal of the European Patent..
Oppositions & Appeals: We helped shape the debate on medical use claim patentability
Case 7 – T 879/12 (EPO Board of Appeal, 27 August 2014)
..
New coronavirus (COVID-19) test allows rapid detection of neutralising antibodies
Our client, Duke-NUS, has helped to develop a new, rapid serological..
BREAKING: G3/19 – an end to the plant patentability saga?
On 14 May 2020, the Enlarged Boards of Appeal of the European Patent..
Singapore's biotech breakthrough
From the far east to the east coast of America, the world is taking..
InVEntions of WWII
VE day on Friday 8 May 2020 is the 75th anniversary of the end of..
Can a functionally defined patent claim ‘protect’ my medicinal product?
From a patent perspective this may seem like a strange question with..
BerGenBio’s bemcentinib selected for fast track as potential treatment for coronavirus (COVID-19)
In the fight against the coronavirus pandemic, bemcentinib produced..
Oppositions & Appeals: We moved the conversation on animal involvement
Case 6 – T 1262/04 (EPO Board of Appeal, 13 July 2012)
..
Coronavirus (COVID-19), big data and silver linings
There is no denying that the COVID-19 pandemic will have tremendous..
Antibody tests for prior infection with SARS-CoV-2 – key tools for monitoring and managing the coronavirus (COVID-19) outbreak
In recent weeks there’s been a lot of discussion in the media of..
What use is computational biology during the coronavirus (COVID-19) pandemic?
There is one obvious way in which computational biology is showing..
A*STAR and MiRXES step up in the fight against coronavirus (COVID-19)
Our Singapore based-clients A*STAR (Agency for Science, Technology..
Neoantigen-targeted adoptive cell therapies – the next frontier in cancer immunotherapy
Cancer immunotherapies harness the power of the patient’s immune..
CRISPR used in gene editing clinical trial for first time
The revolutionary CRISPR gene editing tool has been used inside the..
Microbiome: Meet your multitude
The health and wellbeing of each of us depends upon a number of vast..
Coronavirus (COVID-19): a case study in emerging disease
UPDATE 14 APRIL 2022: In his blog Horizons in vaccine production,..
Bioinformatics - science's big secret
Now deeply woven into the fabric of biological research,..
Oppositions & Appeals: We set the standard for the strawman
Case 5 - T 649/92 (EPO Enlarged Board of Appeal, 2 July 1996)
Bioinformatics, data and healthcare: Benefits and challenges of data-driven medicine
Algorithms (sometimes collectively referred to as ‘digital health’)..
UK will not participate in the Unified Patent Court and Unitary Patent systems
Yesterday the UK Government published its negotiating objectives for..
EPO streamlining: the opposition timeline tightens
Our analysis of patent oppositions has revealed that early action has..
What makes Massachusetts small but mighty?
Deirdre Sanders, president of the Boston Patent Law Association and a..
The evolutionary history of cancer - predicting the disease
Cells can acquire the mutations that drive the development of cancer..
Genomics and Biodata in 2020: the future is here!
I have been working in the field of bioinformatics/computational..
Oppositions & Appeals: we opened the door for different types of data to support a medical use
Case 4 - T 801/06 (EPO Board of Appeal, 4 March 2009)
Now cited in..
Genomics and Biodata in 2020: so much data, so little time?
Having attended the Festival of Genomics & Biodata 2020 conference..
Genetic engineering and synthetic biology – making cannabis production greener
The therapeutic benefits of medicinal cannabis have been liberally..
Enleofen strikes Singapore’s biggest ever biotech deal
In January it was announced that global pharmaceutical company ..
Munich office expansion with high-profile lateral hire
We are delighted to announce the high-profile appointment of Dr...
Farming the great indoors
When you think of a farm, what comes to mind? Rolling fields of green..
Advancements of genetic testing
The sequencing of the first human genome in 2003 was a major..
Oppositions & Appeals: We made the case for a new technical effect
Case 3 - T 1642/06 (EPO Board of Appeal, 23 August 2007)
The..
Simulations in bioinformatics and the G1/19 referral
What’s all this about?
Claims directed to methods of simulation or..
EPO Board of Appeal confirms Broad Institute’s CRISPR patent lacks priority and upholds revocation decision
In one of the most high profile cases of recent years, a European..
AI, deep learning and image analysis in bioinformatics
Putting “AI” in the title of your paper, or indeed in the name of..
Will biomarkers come of age?
The world’s population is ageing. In 2018, for the first time in..
Bioinformatics: biological and medical sciences in the age of big data
What is bioinformatics?
Bioinformatics is a term which we will use as..
Bioinformatics is everywhere!
As discussed in a previous post, most types of biological or medical..
Collagen scaffolds – the future of tissue engineering?
Despite the success of organ transplantation since its inception in..
Gamma/delta T cells emerge as an untapped resource for cancer immunotherapy
Third lymphocyte lineage shows its mettle
B lymphocytes, a type of..
Biomarkers and precision medicine
A biomarker, an amalgamation of the term ‘biological marker’, is a..
Meet the team: Richard Clegg, Partner, European Patent Attorney, Patent Attorney Litigator
Richard Clegg has just come off a phone call with a company in..
New report launched: EPO Opposition Trends in the Life Sciences Sector
Our new research has revealed several recent patterns regarding the..
EPO oppositions: Nine key questions answered
Mewburn Ellis has dug deep into a decade of EPO life sciences'..
Meet the team: Chris Denison, Partner, European Patent Attorney
It doesn’t come terribly naturally, admits Chris Denison, to talk..
Top tips for patenting antibodies in Europe
Antibody development is a mature field of technology. There are..
Oppositions a case to remember: we forced a fuller view of technical features
Case 1 – T 1859/08 ( EPO Board of Appeal, 5 June 2016)
..
Meet The Team: Simon Kiddle, Partner, European Patent Attorney
“As a child I was always interested in the way things work – mucking..
Meet The Team: Katherine Green, Partner, European Patent Attorney
“Arguing with people about molecules is my dream job,” says Katherine..
Meet The Team: Seán Walton, Partner, European Patent Attorney
“Today is the 29th anniversary of my joining Mewburn Ellis,” remarks ..
EPO Bioinformatics Roadshow
There is still a relatively prevalent view in the field of..
Oppositions - a case to remember. Flexibility around added matter
Case 2 – T 0099/13 (EPO Board of Appeal, 14 January 2016)
..
Meet The Team: Emily Hayes, Partner, European Patent Attorney
Employing CRISPR to expose ‘hiding’ cancer cells to immunotherapy
Immunotherapy employs the patient’s immune system against cancer. ..
Renewable energy – huge potential for biofuel innovation
It has been widely reported in the media recently that we need to do..
Controlling genes – the new field of epitranscriptomics
The human genome contains roughly 20,000 genes that encode proteins...
T cell engagers - dark horses of immunotherapy
Chimeric antigen receptor (CAR) technology has attracted a lot of..
Obtaining patent protection for fermentation processes and products – the European perspective
Fermented foods have been known for millennia and form an important..
Food of the future – regulating and protecting gene-edited crops
A recent episode of the BBC World Service’s excellent series “50..
DIY biology dilemma – regulating biohacking
Science kits may have inspired generations of children to become..
Shifting treatments: cancer as a manageable disease
As new treatments drive a shift towards treating cancer as a..
Patentable subject matter in bioinformatics - USPTO’s January 2019 guidance
In this article, Paul Liu and Ashley Barton from Duane Morris LLP..
Challenges Post Selex
Twenty-five years ago Tuerk and Gold reported the Selex method...
The rise of predictive medicine
Thanks to significant advances in genetics, we are not only getting..
Cultured meat - food for thought
Cultured meat is rapidly emerging alongside plant-and..
New Rules of Procedure at the Boards of Appeal – what does this mean for patentees and opponents?
Revised Rules of Procedure at the Boards of Appeal have been approved..
A Myriad of effects
Even though the decision in Myriad is now 6 years old and there have..
Gender medicine – deriving novelty from treating women?
When you hear the term “gender medicine”, what comes to mind? For..
Singapore biotech start-ups: the importance of patent protection
Singapore’s biotech industry plays a key role in shaping the..
Tips from the top: inspiring women in technology
You may be surprised to hear that only 17% of those working in..
EU approves first gene therapy for patients with a mild form of β-Thalassemia
Exciting news in the personalised medicine space – the EU has just..
Precision therapeutics for the precision medicine era
In recent years we have seen dramatic advances in our understanding..
Personalised medicine: patient stratification
While the general idea of customising treatment to patients is not..
Pioneers of precision medicine
Breakthroughs in healthcare promise a future in which the individual..
Dosage regimen patents: bruised but not beaten
Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court..
Playing for time: strategies that can help extend a drug's patent life
In our new magazine Forward, we interview C Hunter Baker of Wolf,..
EPO oral proceedings in Haar - do they infringe a party’s right to be heard?
A new referral to the Enlarged Board raises this question...
The..
Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences
We are entering an age of precision medicine, with patients receiving..
Is your interest legitimate? New referral to the EBOA on double patenting
EPO Board of Appeal 3.3.01 is referring a number of questions..
Plant related inventions: clarity at last?
As we reported previously, EPO Technical Board of Appeal 3304..
Fighting cancer with CAR-T therapies
In September 2018, NHS England entered into an agreement with Novartis
Commercialising genomic research in the US: tips for obtaining patent protection
The field of genomics has seen incredible advances over the past few..
China - a key player in the global precision medicine race
With a growing economy, and a large, ageing population, China is..
Eight key themes from the J.P. Morgan Healthcare Conference
I’ve spent the last few days talking with biotech entrepreneurs, VC..
Precision medicine: ethics, regulation and patent law
New genomic and proteomic analysis technologies allow for diagnosis..
Plant related inventions: the saga continues
We may be approaching the end of the year, but the saga of patents..
Patent protection: five tips for biotech start-ups
Early-stage biotech companies are often founded based on the exciting..
Clovis Oncology success in European Opposition Proceedings related to Rubraca®
Clovis Oncology has announced that the European Patent Office (EPO)..
The importance of Innovation Hubs in the UK's North West Region
Life science ‘start-ups’, ‘spin-outs’ and SMEs are some of the most..
Supreme Court decision signals bad news for patent holders
The UK Supreme Court issued its decision today on the Warner Lambert..
Precision Medicine: the next revolution in healthcare
In recent years, we have witnessed a remarkable healthcare..
Morphosis: creating and nurturing biotech start-ups in Singapore
We understand that early-stage biotech companies do not have it easy...
The pioneering work of Professor Sir Greg Winter
Professor Sir Greg Winter’s pioneering work using phage display for..
Changes to inter partes review system for challenging granted patents
Last week, the U.S. Supreme Court issued two important decisions..